Short structural variants-variants other than single nucleotide polymorphisms-are hypothesized to contribute to many complex diseases, possibly by modulating gene expression. However, the molecular mechanisms by which noncoding short structural variants exert their effects on gene regulation have not been discovered. Here, we study simple sequence repeats (SSRs), a common class of short structural variants. Previously, we showed that repetitive sequences can directly influence the binding of transcription factors to their proximate recognition sites, a mechanism we termed non-consensus binding. In this study, we focus on the SSR termed Rep1, which was associated with Parkinson's disease (PD) and has been implicated in the cis-regulation of the PD-risk SNCA gene. We show that Rep1 acts via the non-consensus binding mechanism to affect the binding of transcription factors from the GATA and ELK families to their specific sites located right next to the Rep1 repeat. Next, we performed an expression analysis to further our understanding regarding the GATA and ELK family members that are potentially relevant for SNCA transcriptional regulation in health and disease. Our analysis indicates a potential role for GATA2, consistent with previous reports. Our study proposes non-consensus transcription factor binding as a potential mechanism through which noncoding repeat variants could exert their pathogenic effects by regulating gene expression.
Introduction
Simple sequence repeats (SSRs; also known as microsatellites or short tandem repeats), including homopolymer stretches, are one of the most polymorphic and abundant repeat classes in the human genome. Recently, there has been increased support for the idea that SSRs, which are largely ignored in largescale genetic studies, may be involved in many human complex diseases and may also contribute significantly to variation in gene expression in humans [1] [2] [3] [4] . SSRs are thought to affect phenotypes by altering the regulation of gene transcription [5] [6] [7] [8] [9] [10] , splicing [11] , and translation, and it is by these mechanisms that SSRs may play a role in the etiology of human diseases. However, the roles of noncoding SSRs in human complex diseases, and specifically the mechanisms whereby SSRs regulate gene expression and exert their pathogenic effects, have yet to be discovered.
Genetic variations associated with Parkinson's disease (PD) risk demonstrated associations with SNCA (MIM: 163890) expression levels. A prominent example is the Rep1 polymorphism, a complex SSR associated with PD risk in diverse populations [12] . Rep1 [6] is a polymorphic dinucleotide repeat site ((TC) n TT(TC) m (TA) x (CA) z where n = 10-11, m = 9-11, x = 7-9, and z = 10-13) located~10 kb upstream of the SNCA transcription start site [13, 14] . The length of Rep1 appears to be associated with increased risk of PD [15] . In particular, most association studies, including a large meta-analysis, have shown that the extended alleles of Rep1 confer increased risk to develop late-onset, Bidiopathic^PD, while the shorter allele is protective [12, [16] [17] [18] [19] . We investigated the effect of the Rep1 polymorphism on SNCA expression and discovered that Rep1 regulates SNCA transcription in human brain tissues [20] . These results have been confirmed using luciferase reporter assay [6, 21] and in a humanized mouse model [22] . The PD-risk Rep1 allele led to increased SNCA-mRNA levels, providing further support for the pathogenic effect of SNCA overexpression [6, 20, 22] . Retrospectively, the Rep1 site was assessed using the SSV evaluation system and had a high score (total impact score = 31) relative to the complete list of SSRs within SNCA genomic regions including ± 50-kb flanking regions [23] . However, the mechanism underlying the effect of Rep1 variants on SNCA transcription remains elusive.
Recently, Afek et al. showed that certain repetitive DNA sequences, when present in the flanking regions of specific transcription factor (TF) binding sites, can significantly affect the intensity of TF-DNA binding through a mechanism termed Bnon-consensus binding^ [24, 25] . In particular, Afek et al. showed that the magnitude of the non-consensus effect can reach 66% of consensus TF-DNA binding, and that non-consensus binding free energy depends on the exact repeat type and on the length of repeated DNA sequence elements [25] . However, the role of the TF non-consensus binding mechanism in the context of the human genome has not been investigated, and its potential implication in the regulation of human gene expression has yet to be discovered.
Here, we propose that the mechanistic role of Rep1 in the differential transcriptional regulation of the SNCA gene may be mediated through non-consensus binding of TFs. Using an in vitro, cell-free system for measuring TF-DNA interactions quantitatively and in high throughput [25, 26] , we studied whether the variable alleles at the Rep1 site show differential non-consensus binding of TFs. We focus on two TF families, GATA and ELK, because (1) they have consensus binding sites in very close proximity to the Rep1 region, and (2) they have been reported to be expressed in the brain and/or play a role in brain development. We found that variable alleles at the Rep1 locus drive differential binding affinities for both TF families. Using expression analysis, we further our understanding regarding the GATA and ELK family members that are potentially relevant to SNCA transcriptional regulation in health and disease.
Materials and methods

Human tissue samples
The TF expression analysis of the human tissues consisted of temporal cortices from individuals with three autopsyconfirmed neuropathological diagnoses: (1) Parkinson's disease (PD; N = 3), (2) dementia with Lewy body (DLB; N = 3), (3) clinically and neuropathologically normal subjects (N = 3), and blood samples from cognitively healthy subjects (N = 3). The projects were approved by the Duke Institutional Review Board and followed appropriate ethical protocols, and all experiments were performed in accordance with relevant guidelines and regulations.
The brain tissues were obtained through the Layton Aging and Alzheimer's Disease Center at Oregon Health and Science University. Subjects (or their legally authorized representatives) provided informed consent for their data and brain specimens to be used in future research.
RNA extraction and cDNA synthesis
Total RNA was extracted from human temporal cortex, blood samples, and human induced pluripotent stem cell (hiPSC)-derived neurons, using TRIzol reagent (Invitrogen) followed by purification with an RNeasy kit (Qiagen) used as per the manufacturer's protocol. RNA concentration was determined spectrophotometrically at 260 nm, while the quality of the purification was determined by 260/280 nm ratio that showed values between 1.9 and 2.1, indicating high RNA quality.
cDNA was synthesized using MultiScribe RT enzyme (Applied Biosystems) using the following conditions: 10 min at 25°C and 120 min at 37°C.
Real time PCR
Real-time PCR was used to quantify the levels of the transcription factors (TFs). Briefly, samples were assayed by relative quantitative real-time PCR using TaqMan expression assays and the ABI QuantStudio 7 to determine the level of the message RNA (mRNA) of the TFs relative to mRNAs encoding housekeeping genes. ABI MGB probe and primer set assays (Applied Biosystems) that were used to amplify the target transcription factors and the housekeeping reference controls are listed in Supplementary Table S1 . Each cDNA (10 ng) was amplified in duplicate in at least two independent runs (overall ≥ 4 repeats), using TaqMan Universal PCR master mix reagent (Applied Biosystems) and the following conditions: 2 min at 50°C, 10 min at 95°C, 40 cycles: 15 s at 95°C, and 1 min at 60°C. As a negative control for the specificity of the amplification, we used RNA control samples that were not converted to cDNA (no-RT) and no-cDNA/ RNA samples (no-template) in each plate. No amplification product was detected in control reactions. Data were analyzed with a threshold set in the linear range of amplification. The cycle number at which any particular sample crossed that threshold (Ct) was then used to determine fold difference, whereas the geometric mean of the two control genes served as a reference for normalization. Fold difference was calculated as 2 −ΔΔCt [50] : 
Statistical association analyses
Expression measurements of the different TF-mRNAs in human tissues represent three subjects each repeated four times, and in iPSC-derived cells represent four biological and technical replicates. Statistical significance of differences in expression between the samples for each TF was analyzed by pairwise comparisons using the Tukey-Kramer HSD test (JMP Pro13, SAS).
Recombinant protein expression and purification
Gateway-compatible clones containing the full-length genes for GATA family protein Gata1 and ELK protein Elk1 were purchased from GeneCopoeia and the genes were transferred into pDEST15 using the LR Clonase reaction (Life Technologies). This vector enables the production of Nterminally glutathione S-transferases (GST)-tagged proteins. Cells were grown in LB broth to an OD 600 of 0.4 to 0.6 and then expression was induced with IPTG at 30 to 37°C. Pelleted cells were frozen and stored at − 20°C, and thawed cells were lysed with lysozyme. GST-tagged protein was purified from the soluble portion of the lysate using GST resin (GE Healthcare) according to manufacturer's instructions.
Design of the DNA library for protein-DNA binding assays
Custom protein-DNA binding experiments based on the protein-binding microarray (PBM) technology [25, 26, 33, 51, 52] can be used to test TF binding up to tens of thousands of custom sequences of up to 36 bp long. Here, we designed a custom DNA library based on the Rep1 genomic region (chr4: 90767174-90767251, GRCh37/hg19). Taking 50 bp upstream of Rep1 plus 10 bp of the repeat region, and showing it on the reverse strand, the genom ic sequence is CAC A C A C A C A C G G A A G G C AT C A G A T A T C T C A TGTGTGTATACACATACATATATATAGG, where the two bold underlined sequences are core binding motifs for ELK and GATA, respectively, and the italic sequence represents the first 10 bases of the Rep1 region. On the reverse strand, the Rep1 region is (TC) n TT(TC) m (TA) x (CA) z , where n = 10-11, m = 9-11, x = 7-9, and z = 10-13. Since probes in custom PBM libraries are limited to 36 bp, in order to test the influence of Rep1 repeats on binding of GATA and ELK to DNA, we designed sets of probes that contain the GATA and/or ELK sites in their immediate genomic flanks, followed by all possible combinations of repeats based on the Rep1 alleles. Specifically, we designed the following sets of probes:
1. Probes with no specific binding sites, to use as negative controls. These probes contain all possible overlapping 36mers generated from all possible 144 combinations of the Rep1 repeats. 2. BELK binding site^probes, which contain the ELK core binding site in its immediate genomic context (CGGAA GGCATCAG) preceded by 23-bp sequences designed according to all possible combinations of repeats found in Rep1 alleles. 3. BGATA binding site^probes, which contain the GATA core binding site in its immediate genomic context (ATCAGATATCTCATG) preceded by 21-bp sequences designed according to all possible combinations of repeats found in Rep1 alleles. 4. BELK+GATA binding sites^probes, which contain both the ELK and the GATA core binding sites in their genomic context (CGGAAGGCATCAGATATCTCATG) followed by 13-bp sequences designed according to all possible combinations of repeats found in Rep1 alleles. 5. Probes designed from another repeat region potentially relevant for SNCA expression, which we call the BPure CA^region (chr4: 90636808-90636841, GRCh37/hg19). A consensus binding site for the GATA family is located i n c l o s e p r o x i m i t y t o t h i s r e g i o n : … C A C A CACACACTTTTATATCTTTTC (10 bases of the CA repeat are shown in italic font; the reverse complement of the GATA core binding site is shown in bold underlined font). Based on this repeat region, we designed probes containing the genomic region upstream of the repeat, followed by CA repeats of different lengths, and by the GATA site in its immediate flanking sequence.
For all probes, the 36-bp custom sequence was followed by a constant 24-bp sequence (GTCTTGATTCGCTTGACGCT GCTG) complementary to a primer used for primer extension in order to double-strand the DNA (see below).
In vitro protein-DNA binding assays
Custom protein-DNA binding experiments were carried out following the standard protein-binding microarray (PBM) protocol [26, 33] but using the custom DNA library described above. Briefly, we first performed primer extension to obtain double-stranded DNA oligonucleotides on the microarray. Next, each microarray chamber was incubated with a 2% milk blocking solution for 1 h, followed by incubations with a PBSbased protein binding mixture [33] for 1 h (containing either 75 nM GATA1 or 65 nM ELK1 recombinant protein) and with Alexa488-conjugated anti-GST antibody (1:40 dilution, Invitrogen A-11131) for 1 h. The array was gently washed as previously described [33] and then scanned using a GenePix 4400A scanner (Molecular Devices) at 2.5-μm resolution. All blocking and washing solutions contained 50 μM zinc acetate, as recommended for zinc-finger proteins, including GATA [33] . Data were normalized with standard analysis scripts [26, 33] . The normalized data were further processed to compute median values over replicate spots containing identical DNA sequences. The raw and processed data generated in this study is currently being submitted to GEO.
Data availability All data generated or analyzed during this study are included in this published article (and its Supplementary Information files), or available from the corresponding author on reasonable request.
Results
Two potential transcription factor binding sites are located in very close proximity to the Rep1 repeat region
We analyzed the genomic region in the neighborhood of Rep1 to identify putative TF binding sites, using the TF binding specificity databases UniPROBE and cisBP [27, 28] . We identified an ELK binding site (CGGAAGGC) located right downstream of the Rep1 region (on the reverse strand, as SNCA is encoded on the reverse stand), and a GATA binding site (AGATATCTCA) located three nucleotides downstream of the ELK site (on the reverse strand). ELK proteins, which include ELK1, ELK3, and ELK4 in human, are part of the ETS structural family of transcription factors. All three ELK human proteins bind to sequences containing the TTCC /GGAA core motif, and their DNA-binding preferences are indistinguishable according to existing binding data [29] . Thus, we selected one of the ELK proteins, ELK1, to investigate the effects of repeat sequences on ELK binding to DNA. The GATA protein family also contains multiple TFs (GATA1 through GATA6) with indistinguishable DNA-binding specificities. Thus, as a representative of the GATA family, we selected GATA1 to investigate the effects of repeats on its DNA-binding affinity. Interestingly, members of both GATA and ELK transcription factor families play important roles in brain development and function [30] and some have even been shown to regulate the expression of the SNCA gene [31, 32] , albeit through regulatory regions distinct from the Rep1 region studied here. Thus, the proximity of ELK and GATA binding sites to the Rep1 region, together with the known effects of Rep1 alleles on SNCA gene expression, led us to hypothesize that the length of different repeat units that comprise the Rep1 region could have a direct influence on ELK and/ or GATA binding at this genomic site. We tested this hypothesis using a quantitative, cell-free protein-DNA binding assay.
Briefly
.e., (TC) n TT(TC) m , (TC) m (TA) x , and (TA) x (CA) z , for their effects on GATA and/or ELK binding (BMaterials and methods^). We synthesized the DNA oligos on a chip and we used the protein-DNA binding microarray technology (PBM) [26, 33] to quantitatively measure binding of recombinant GATA and ELK proteins to thousands of sites containing Rep1 repeat elements of different lengths. First, though, we confirmed that GATA and ELK do indeed bind with high specificity to the consensus sites we identified next to the Rep1 region (Fig. 1) . We note that although PBM assays measure TF-DNA binding in a cell-free system, previous work from our group and others has demonstrated that this technology can reveal new insights into TF binding mechanism in living cells [34, 35] .
Repetitive elements in the Rep1 region have significant effects on GATA and ELK binding to DNA Next, we analyzed the GATA and ELK binding signals for probes containing repeats of different lengths. Given the relatively short length of the probes that can be used in quantitative binding assays, testing the full Rep1 alleles followed by the ELK and GATA sites is not feasible. Instead, for each repeat element in the Rep1 region (TC) n TT(TC) m (TA) x (CA) z , we tested the effect on GATA and ELK binding to their consensus site flanked by 1, 2, 3, 4,… repeated units of each type of repeat (CA, TA, and TC). We preserved the genomic context as much as possible, given the technical limitation that probes can contain at most 36 custom base pairs.
Consistent with our hypothesis, we found that the lengths of the Rep1 repeat components have significant effects on GATA and ELK binding to their consensus binding sites (Fig. 2) . For all three repeat types (CA, TA, and TC), longer repeats are significantly correlated with higher binding affinities for both GATA (Fig. 2a) and ELK (Fig. 2b) , when the repeats are located right next to the transcription factor binding sites. Overall, the effect of the individual repeat types on TF binding in the context of Rep1 is very complex (Supplementary Fig. 1 ). The structure of Rep1 is complex and contains different repeat components in tandem. Therefore, in the design of our DNA library, increasing the length of one repeat (e.g., (CA) z ) is done simultaneously with decreasing the length of another repeat (e.g., (TA) x ), in order to keep the total length of the oligos constant within the native genomic context. Thus, the measured effects on TF binding could come from either, or both, of the repeat components in each probe. Nevertheless, our analysis of a Bpure^CA polymorphic site showed that increasing the length of a CA repeat in the proximity of a GATA consensus binding site leads to increased GATA binding (discussed below and Fig. 3 ). The TT component in the Rep1 region also adds to the complexity. As shown in Fig. 2 (lower panels) , increasing the length of the (TC) m component leads to increased GATA and ELK binding. However, as the length of the (TC) m component increases, the TT component moves further apart from the transcription factor binding site. One could consider the TT component as Bbreaking^a long (TC) n + m repeat. In this interpretation, the location of the break, relative to the transcription factor binding site, could be causal for the effect we observed on binding of GATA and ELK to DNA. Additional binding studies and biochemical characterization would be needed to further understand the mechanisms by which these sequence repeats have a direct effect on TF binding.
Given the importance of the CA repeat component in the Rep1 region [21, 22] , and to further our understanding of the contribution of CA repeats in their native genomic context, we searched for a Bpure^CA polymorphic site that has a potential TF binding site in its close proximity. We identified a BpureĈ A repeat variant (rs10586902) nearby a GATA site in the SNCA gene noncoding flanking region (chr4: 90636808-90636841, GRCh37/hg19), positioned within a potentially regulatory sequence (ENCODE). We tested the effect of the CA repeat length on GATA binding in the genomic context of this Bpure^CA variant. Consistent with our results on the Rep1 region, longer CA repeats in this polymorphic region lead to stronger GATA binding to its consensus site located right next to the repeat variant (Fig. 3) . This finding is also consistent with our previous in vitro and in vivo observation that Rep1 alleles with longer CA components drive higher transcription of SNCA gene [21, 22] .
Characterization of the expression of GATA and ELK families in brain tissues relevant to PD and DLB While the DNA-binding specificities of GATA and ELK factors are expected to be identical within their respective protein families, each family member may be expressed at different levels across various tissue and cell types. Thus, we next sought to gain insights into which ELK and GATA transcription factors are potentially relevant for the regulation of SNCA transcription in the context of synucleinopathies. We characterized the mRNA expression of TFs of the GATA and ELK families in human brain cortical tissues from healthy and disease donors and in blood samples from healthy subjects. We compared the mRNA expression levels among the different neuropathologies, i.e., PD, DLB, and normal, and between tissues, i.e., normal brain vs. blood (summarized in Supplementary Table S2) . Each tested transcription factor showed a distinct expression profile across the analyzed tissues (Fig. 4) . GATA1, GATA3, and ELK3 were predominantly expressed in the blood (p < 0.0001), and no significant differences were observed among the different neuropathologies. GATA2 and GATA6 expressions in normal blood were also higher compared to normal cortex but in a lesser extent (p = 0.005, 0.09), while ELK1 levels showed an opposite trend. Overall, no significant trends were observed among the cortex tissues from the different diagnoses. However, several TFs showed higher mean levels in the cortex from disease compared to normal, particularly DLB > normal, that warrant investigations using a larger sample size (Fig. 4 and Supplementary Table S2) .
GATA2 was the most abundant TF in the human brain cortex samples, approximately two-to threefold increase across each pathology. Thus, we have prioritized GATA2 for further studies using iPSC-derived neurons from an apparently healthy control (Control), and from a patient with the triplication of the SNCA gene (SNCA-tri). GATA2 expression was elevated in mature dopaminergic and cholinergic neurons derived from disease and normal iPSC lines compared to neuronal precursor cells (NPCs), but no further changes were observed upon inducing aging (Supplementary Fig. S2a ). Consistently, SNCA-mRNA expression increased throughout neuronal maturation, i.e., NPC < mature neurons. However, although induced aging did not affect GATA2 expression, with the exception of normal cholinergic neuron, the expression of SNCAmRNA slightly further increased in the aged neurons ( Supplementary Fig. S2b ). Noteworthy, in each stage (NPC, mature neurons, and aged) for both iPSC sources (patient and normal), GATA2 expression was significantly higher (p < 0.0001) in the cholinergic lineage compared to the dopaminergic cells (Supplementary Fig. S2 ). Thus, GATA2 emerged as the top candidate transcription factor for future follow-up studies, as discussed below. 
Discussion
Changes in expression levels of specific genes in the brain are associated with late-onset neurodegenerative diseases, and these expression changes are genetically regulated [36] [37] [38] . A prominent example is the SNCA gene and the contribution of alteration in its expression to the etiology of synucleinopathies [36, [38] [39] [40] [41] [42] [43] [44] [45] . Therefore, it is highly important to reveal the genetic mechanisms underpinning the differential expression of SNCA and other key genes. Transcription is one of the mechanisms that contribute to gene expression and it involves interactions between cis elements-DNA sequences-and trans factors-transcription factors. The simple sequence repeat (SSR) region Rep1 has been suggested to act as an enhancer element of SNCA gene. Here, we identified potential TFs, GATA and ELK families, that bind proximate to Rep1 and whose binding affinities are influenced directly by the Rep1 sequence. Although our results do not exclude the influence of other cellular factors (such as nucleosomes), they do suggest that the role of Rep1 in modulating SNCA transcription may be mediated, at least in part, by its effect on GATA/ELK binding via the non-consensus mechanism.
Studies using human brain tissues [20] , luciferase reporter assay [6, 21] , and humanized mouse model [22] showed the role of Rep1 in the regulation of SNCA-mRNA levels. However, these results conflict with the recent findings that showed no effect of Rep1 on SNCA-mRNA level using genome-edited iPSC-derived neurons [46] . It is possible that difficulties in quantifying the total SNCA transcript levels affected the validity of the reported conclusions. Therefore, we and calculated relatively to the geometric mean of GAPDH-mRNA and PPIA-mRNA reference controls using the 2 −ΔΔCT method. Each column represents the mean of four biological and technical replicates. The error bars represent the S.E.M. Fig. 3 The length of the CA repeats in a Bpure^CA polymorphic site has a significant effect on GATA1 binding to its consensus site in the proximity of the repeat. The boxplot shows the natural logarithm of the florescence intensity measured by PBM (BMaterials and methods^). Each box shows the binding signal at 10 replicate DNA spots randomly distributed across the glass surface. The central mark indicates the median of the replicates, and the bottom and top edges of each box indicate the 25th and 75th percentiles, respectively. The whiskers extend to the most extreme data points, excluding outliers cannot rule out the possibility of a false negative for the SNCA-Rep1 finding reported by Soldner et al. [46] . Low abundance of relevant TFs in their cellular model system may explain the challenges they encountered to detect an effect.
Noteworthy, other groups have shown that GATA TFs bind to elements within intron 1 [31] and the promoter [32] of SNCA, where they have been proposed to play a role as inducers of transcription. Consistently with these previous reports, we showed that, among the GATA family members, GATA2 is highly abundant in human cortex, suggesting that GATA2 plays a role in the regulation of SNCA transcription. Thus, we have prioritized GATA2 for further studies and conducted analysis of expression profiles in iPSC-derived dopaminergic and cholinergic neurons as in vitro models for PD and DLB, respectively [47] . We showed higher levels in cholinergic derived cells, inferring that GATA2 may exert a differential contribution to the etiologies of DLB vs. PD that warrants in-depth investigations using single-cell analyses and model systems.
Previously, we showed that Rep1 plays a role in the transcriptional regulation of SNCA, and that the variable alleles led to differential expression of the SNCA gene [6, 20, 22] [21]. Here we investigated the mechanism underlying the transcription role of Rep1. We dissected the extent of the effect of each component of the Rep1 sequence and found that the CA component contributes substantially to the non-consensus binding. These results are consistent with our previous finding showing the contribution of the CA length to the levels of SNCAmRNA in human brains [20] , humanized mice [22] , and luciferase reporter system [6, 21] .
The results of this in vitro study suggest that Rep1 variants have the potential to significantly affect binding of TFs to their genomic regulatory sites, via the non-consensus binding mechanism, which in turn could regulate SNCA-mRNA expression levels. The direct impact of the non-consensus TF binding of Rep1 on SNCA-mRNA levels warrants further investigations using in vivo model systems. However, such investigations are not trivial. The genomic binding of TFs in the cell is typically tested with chromatin immunoprecipitation (ChIP) assays; however, traditional ChIP assays are not sufficient to directly compare TF binding between samples [48] (in our case, samples with different Rep1 alleles). Furthermore, robust in vivo testing will require the generation of multiple isogenic cell-lines with the various Rep1 alleles. Therefore, in vivo testing of all the variants tested in our cell-free binding assay may not even be feasible. Nevertheless, our comprehensive cell-free assay provided the initial mechanistic evidence, as well as good candidates TF and repeat elements. These results established the foundation for further testing in future follow-up studies using a new developed cell-based system in combination with sensitive ChIP-based assays.
In conclusion, using the Rep1 repeat variant upstream of the SNCA gene as a prototype, we provided initial support for the proposed general phenomenon that differential nonconsensus binding of transcription factors to the variable alleles at repeat sequence sites is likely to be responsible, at least in part, for differential expression of the cis-regulated genes. In fact, we have initiated follow-up experiments for two additional polymorphic SSRs in SNCA region that are likely to be functional [23, 49] , both of which exhibit strong potential binding sites for neuronal TFs ± 50 bp of the repeat site and are strong candidates for the non-consensus binding effect. Our study serves as a model for future investigations aiming to explore the effect of other noncoding polymorphic repeat sequences on transcriptional regulation in the human brain, in relation to neurodegenerative diseases in aging.
